EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology

Mariana Martins Monteiro, Elcidimar Lucas Aleixo de Castro iD, Ana Júlia Moaraes Pereira, Roberto Thiesen iD, Roberta Martins Crivelaro Thiesen, Felipe Masiero Salvarani iD

Viruses · 29.09.2025 · 17 (10) · 1322

DOI: 10.3390/v17101322 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 29.09.2025. Verfasst von Mariana Martins Monteiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Veterinária, Universidade Federal do Pará, Castanhal 68740-970, PA, Brazil. Hauptthemen laut MEDLINE: Horse Diseases, Immunotherapy, Skin Neoplasms, BCG Vaccine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Equine sarcoids are the most common dermatological neoplasm in horses worldwide, associated with bovine papillomavirus (BPV) infection and characterized by high recurrence rates after conventional therapies. Bacillus Calmette–Guérin (BCG) immunotherapy has historically been used for sarcoid treatment, yet its role in contemporary veterinary oncology remains debated. This narrative review critically examines the immunological mechanisms, clinical efficacy, and limitations of BCG in equine sarcoid therapy, while integrating insights from comparative oncology and One Health perspectives. A systematic search following PRISMA-based criteria identified 55 relevant studies published over the past four decades. Evidence indicates that BCG activates innate and adaptive immunity through TLR2/4 signaling, macrophage polarization, and enhanced CD8+ T-cell responses, leading to partial or complete sarcoid regression in select cases. However, therapeutic outcomes are highly variable due to heterogeneity in protocols (dose, strain, adjuvant use) and frequent adverse inflammatory reactions. Comparative analyses highlight that modern alternatives—such as cryotherapy, cisplatin-based protocols, and topical imiquimod—achieve higher efficacy and lower recurrence rates in many clinical settings. Although BCG is now rarely considered a first-line therapy, it remains relevant in resource-limited regions, such as the Amazon Biome, where cost-effectiveness and accessibility are critical. Future directions include randomized controlled trials, standardized protocols, and innovative approaches such as checkpoint inhibition, CRISPR-Cas9 targeting of viral oncogenes, and nanoparticle delivery systems. This review provides a balanced and data-driven synthesis of BCG immunotherapy, clarifying its historical contributions, current limitations, and translational opportunities for advancing equine and comparative oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Horse DiseasesImmunotherapySkin NeoplasmsBCG VaccineSarcoidosisAnimalsHorsesTreatment OutcomePapillomavirus Infections

Stichwörter der Autor:innen

BCG immunotherapybovine papillomavirus (BPV)comparative oncologyequine sarcoidveterinary immunology

Substanzen

BCG Vaccine

Autor:innen und Institutionen

  • Instituto de Medicina Veterinária, Universidade Federal do Pará, Castanhal 68740-970, PA, Brazil.

ORCID-Profile: Elcidimar Lucas Aleixo de Castro, Roberto Thiesen, Felipe Masiero Salvarani

Zitieren

APA

Monteiro, M. M., de Castro, E. L. A., Pereira, A. J. M., Thiesen, R., Thiesen, R. M. C., & Salvarani, F. M. (2025). BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology. Viruses, 17(10), 1322. https://doi.org/10.3390/v17101322

Vancouver

Monteiro MM, de Castro ELA, Pereira AJM, Thiesen R, Thiesen RMC, Salvarani FM. BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology. Viruses. 2025;17(10):1322. doi:10.3390/v17101322

BibTeX
@article{Monteiro2025,
  author = {Monteiro, Mariana Martins and de Castro, Elcidimar Lucas Aleixo and Pereira, Ana Júlia Moaraes and Thiesen, Roberto and Thiesen, Roberta Martins Crivelaro and Salvarani, Felipe Masiero},
  title = {BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1322},
  doi = {10.3390/v17101322}
}
Kostenlos starten →